RYRihab Yassin

Rihab Yassin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rihab Yassin has a total of 7 co-authors. Here are the top co-authors by number of shared publications:

  • Nicole Lockhart

    Office of Biorepositories and Biospecimen Research, National Cancer Institute, National Institutes of Health, Bethesda, MD

    2 shared publications
  • Carol J. Weil

    Division of Cancer Treatment and Diagnosis, Diagnostics Evaluation Branch, Cancer Diagnosis Program, National Cancer Institute, National Institutes of Health, Bethesda, USA

    1 shared publication
  • Carolyn Compton

    Office of Biorepositories and Biospecimen Research, National Cancer Institute, Bethesda, MD

    1 shared publication
  • Jeffrey W. Thomas

    Technology Transfer Center, National Cancer Institute, Bethesda, MD

    1 shared publication
  • Karen Pitt

    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD

    1 shared publication
  • Linda Weiss

    Office of Cancer Centers, National Cancer Institute, Bethesda, MD

    1 shared publication

Latest Publications

  • Open Access

    Sharing Individual Research Results with Biospecimen Contributors: Point

    by Rihab Yassin, Carol Weil, Nicole Lockhart

    Biospecimens are an essential resource for biomedical research, including research that aims to decipher the biology of cancer and improve its clinical management. Accordingly, patients with cancer and others who contribute biospecimens for research are increasingly attentive to the results of


  • Open Access

    Custodianship as an Ethical Framework for Biospecimen-Based Research

    by Rihab Yassin, Nicole Lockhart, Mariana González del Riego, Karen Pitt, Jeffrey W. Thomas, Linda Weiss, Carolyn Compton

    Human biological specimens (biospecimens) are increasingly important for research that aims to advance human health. Yet, despite significant proliferation in specimen-based research and discoveries during the past decade, research remains challenged by the inequitable access to high-quality biospecimens that are collected under rigorous ethical standards. This is primarily caused by the complex level of control and ownership exerted by the myriad of stakeholders involved in the biospecimen research process. This article discusses the ethical model of custodianship as a framework for biospecimen-based research to promote fair research access and resolve issues of control and potential conflicts between biobanks, investigators, human research participants (human subjects), and sponsors. Custodianship is the caretaking obligation for biospecimens from initial collection to final dissemination of research findings. It endorses key practices and operating principles for responsible oversight of biospecimens collected for research. Embracing the custodial model would ensure transparency in research, fairness to human research participants, and shared accountability among all stakeholders involved in biospecimen-based research. Cancer Epidemiol Biomarkers Prev; 19(4); 1012–5. ©2010 AACR.